FdaApplication
BLA 020032
Identifiers
- fda_app_no: BLA020032
Properties
| Property | Value |
|---|---|
| applicant_name | AbbVie Inc. |
| application_type | BLA |
| approval_date | 1991-07-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SURVANTA | BERACTANT | 100MG/4ML (25MG/ML) | Suspension |
| SURVANTA | — | 200MG/8ML (25MG/ML) | Suspension |
2 products